Cytek Biosciences Inc (CTKB)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — |
| Total assets | US$ in thousands | 494,457 | 519,476 | 463,305 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $494,457K
= 0.00
The debt-to-assets ratio for Cytek Biosciences Inc for the past three years (2021, 2022, and 2023) has been consistently at 0.00. This indicates that the company has not used debt to finance its operations and investments during these periods. A debt-to-assets ratio of 0.00 suggests that the company has financed its assets entirely with equity, which might reflect a conservative financial strategy. However, it is important to note that a low or zero debt-to-assets ratio may also imply missed opportunities for leveraging debt to potentially enhance returns. Further analysis of the company's capital structure and overall financial health would provide a more comprehensive assessment of Cytek Biosciences Inc's financial position.
Peer comparison
Dec 31, 2023